Prescription Drugs: Spending, Use, and Prices

Congressional Budget Office

No 57050, Reports from Congressional Budget Office

Abstract: Prescription drugs have become an increasingly important part of U.S. health care, as evidenced by the growth in nationwide spending on those drugs from 1980 to 2018. Over that period, such spending increased more than tenfold in real terms (that is, with the effects of economywide inflation excluded). This report by CBO discusses trends in nationwide spending on prescription drugs in the retail market from 1980 to 2018. It also presents a detailed analysis of trends in spending, use, and prices in the Medicare Part D and Medicaid programs over the 2009–2018 period.

JEL-codes: I11 I13 I18 L65 (search for similar items in EconPapers)
Date: 2022-01-19
New Economics Papers: this item is included in nep-ias and nep-ind
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cbo.gov/system/files/2022-01/57050-Rx-Spending.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cbo:report:57050

Access Statistics for this paper

More papers in Reports from Congressional Budget Office Contact information at EDIRC.
Bibliographic data for series maintained by (communications@cbo.gov).